Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 55.422353143587 USD Million |
| 2019 | 57.153292804335 USD Million |
| 2020 | 59.1098477190846 USD Million |
| 2021 | 62.2052958770265 USD Million |
| 2022 | 66.004182 USD Million |
| 2023 | 70.7020486491695 USD Million |
| 2024 | 76.5773560266827 USD Million |
| 2025 | 84.0117240264673 USD Million |
| 2026 | 93.5455143635266 USD Million |
| 2027 | 105.960151440608 USD Million |
| 2028 | 122.411949206554 USD Million |
| 2029 | 144.655480597682 USD Million |
| 2030 | 175.427207266782 USD Million |
| 2031 | 219.125093830459 USD Million |
| 2032 | 283.053772107202 USD Million |
Data Source: Wantstats Repository
Market Dynamics
Stem cell therapy is fast emerging as an effective non-invasive treatment option for a variety of diseases and tissues in the Asia-Pacific region, including neurodegenerative conditions such as Parkinson’s and Alzheimer’s diseases, and spinal cord injury. Advances in stem cell research have enabled the use of mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) to be used for tissue engineering and cell therapy, allowing the development of customised treatments for patients. In the Asia Pacific region, there are a growing number of private and public healthcare initiatives, such as the Singapore Stem Cell Consortium and the Asian Biotherapeutics & Bio-manufacturing Initiative (ABBI) led by the Singapore Economic Development Board, that are driving the development of stem cell therapy in the region. These initiatives are providing funding and resources to support research and clinical trials, in addition to encouraging collaborations and exchanges between researchers and clinicians from all over the world. Moreover, major market players such as Asterias Biotherapeutics, Cell Medica, and GC Pharma are investing in the Asia-Pacific region to expand their presence in the region.
The market players are also adopting various strategies such as collaborations, partnerships, and agreements to gain a competitive edge in the stem cell therapy market in the region. Traditional knowledge and innovation in the field of regenerative medicine is also helping to accelerate the adoption of stem cell therapies in the region. The rising number of hospitals and research institutes in the Asia-Pacific region are also promoting stem cell therapy as a therapeutic option for diseases that are otherwise difficult to treat. In addition, increasing awareness among patients, governments, and healthcare providers regarding the potential benefits of stem cell therapy are helping to boost the market’s growth in the Asia Pacific region. Government initiatives, strong economic growth, and the increasing number of medical reimbursement policies in the Asia-Pacific region are also key factors fueling the growth of the Asia-Pacific stem cell therapy market. Going forward, the expansion of healthcare insurance coverage in the region and the increasing number of clinical trials are expected to provide a further boost to the market growth in Asia-Pacific.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



